Publications | Lund University Publications

1 – 8 of 8

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22J%C3%A4dersten%2C+Martin%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22J%C3%A4dersten%2C+Martin%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2023
Mark Characterization of therapy-related acute myeloid leukemia : increasing incidence and prognostic implications
Nilsson, Christer ; Linde, Fredrika ; Hulegårdh, Erik ; Garelius, Hege ; Lazarevic, Vladimir ^LU ; Antunovic, Petar ; Cammenga, Jörg ^LU ; Deneberg, Stefan ; Jädersten, Martin and Björkvall, Cecilia Kämpe , et al. (2023) In Haematologica 108(4). p.1015-1025
- Contribution to journal › Article
Mark Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option
Dolinska, Monika ; Cai, Huan ; Månsson, Alma ; Shen, Jingyi ; Xiao, Pingnan ; Bouderlique, Thibault ; Li, Xidan ; Leonard, Elory ; Chang, Marcus and Gao, Yuchen , et al. (2023) In Blood 142(1). p.73-89
- Contribution to journal › Article
2022
Mark A risk score based on real-world data to predict early death in acute promyelocytic leukemia
Österroos, Albin ; Maia, Tânia ; Eriksson, Anna ; Jädersten, Martin ; Lazarevic, Vladimir ^LU ; Wennström, Lovisa ; Antunovic, Petar ; Cammenga, Jörg ^LU ; Deneberg, Stefan and Lorenz, Fryderyk , et al. (2022) In Haematologica 107(7). p.1528-1537
- Contribution to journal › Article
Mark Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia : Results from the HEAT-AML trial
Jädersten, Martin ; Lilienthal, Ingrid ; Tsesmetzis, Nikolaos ; Lourda, Magda ; Bengtzén, Sofia ; Bohlin, Anna ; Arnroth, Cornelia ; Erkers, Tom ; Seashore-Ludlow, Brinton and Giraud, Géraldine , et al. (2022) In Journal of Internal Medicine 292(6). p.925-940
- Contribution to journal › Article
2021
Mark Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? : A population-based study
Rosso, Aldana ^LU ; Juliusson, Gunnar ^LU ; Lorenz, Fryderyk ; Lehmann, Sören ; Derolf, Åsa ; Deneberg, Stefan ; Jädersten, Martin ; Antunovic, Petar ; Cammenga, Jörg ^LU and Möllgård, Lars , et al. (2021) In Leukemia & Lymphoma 62(8). p.1973-1981
- Contribution to journal › Article
2020
Mark The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting
Juliusson, Gunnar ^LU ; Jädersten, Martin ; Deneberg, Stefan ; Lehmann, Sören ; Möllgård, Lars ; Wennström, Lovisa ; Antunovic, Petar ; Cammenga, Jörg ^LU ; Lorenz, Fryderyk and Ölander, Emma , et al. (2020) In Blood Advances 4(6). p.1094-1101
- Contribution to journal › Article
2019
Mark Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period
Juliusson, Gunnar ^LU ; Hagberg, Oskar ^LU ; Lazarevic, Vladimir Lj ^LU ; Ölander, Emma ; Antunovic, Petar ; Cammenga, Jörg ^LU ; Wennström, Lovisa ; Möllgård, Lars ; Brune, Mats and Jädersten, Martin , et al. (2019) In Blood 134(18). p.1558-1561
- Contribution to journal › Letter
2011
Mark Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
Mollgard, Lars ; Saft, Leonie ; Treppendahl, Marianne Bach ; Dybedal, Ingunn ; Norgaard, Jan Maxwell ; Astermark, Jan ^LU ; Ejerblad, Elisabeth ; Garelius, Hege ; Dufva, Inge Hogh and Jansson, Monika , et al. (2011) In Haematologica 96(7). p.963-971
- Contribution to journal › Article

your query:: Remove author: Jädersten, Martin